Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
International Journal of Clinical Practice
|
February 11, 2012
Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry
U Zeymer, R Dechend, E Deeg, et al.
Der Internist
|
June 1, 1996
[Thrombolytic therapy of renal artery embolism. An expanded case report with review of the literature]
D C Gulba, M Gross, R Dechend, et al.
Contributions to Nephrology
|
November 14, 2001
Angiotensin-induced inflammation and vascular injury
D N Müller, R Dechend, A Fiebeler, et al.
Advances in Nephrology From the Necker Hospital
|
November 6, 2001
Angiotensin-induced inflammation and novel approaches to treatment
D N Müller, R Dechend, A Fiebeler, et al.
Circulation
|
September 29, 1999
Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis
R Dechend, M Maass, J Gieffers, et al.
Journal of Reproductive Immunology
|
July 1, 2016
The association between angiogenic markers and fetal sex: Implications for preeclampsia research
L B Andersen, J S Jørgensen, F Herse, et al.
Oncogene
|
June 11, 1999
The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators
R Dechend, F Hirano, K Lehmann, et al.
Placenta
|
June 12, 2004
Pre-eclampsia as a 'three stage problem'--a workshop report
H Stepan, R Faber, U G Froster, et al.
International Journal of Cardiology
|
March 12, 2013
Ambulatory blood pressure monitoring: is it mandatory for blood pressure control in treated hypertensive patients?: prospective observational study
M V Lehmann, U Zeymer, R Dechend, et al.
American Journal of Hypertension
|
June 20, 2001
Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition
R Dechend, A Fiebler, C Lindschau, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
International Journal of Clinical Practice
|
February 11, 2012
Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry
U Zeymer, R Dechend, E Deeg, et al.
Der Internist
|
June 1, 1996
[Thrombolytic therapy of renal artery embolism. An expanded case report with review of the literature]
D C Gulba, M Gross, R Dechend, et al.
Contributions to Nephrology
|
November 14, 2001
Angiotensin-induced inflammation and vascular injury
D N Müller, R Dechend, A Fiebeler, et al.
Advances in Nephrology From the Necker Hospital
|
November 6, 2001
Angiotensin-induced inflammation and novel approaches to treatment
D N Müller, R Dechend, A Fiebeler, et al.
Circulation
|
September 29, 1999
Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis
R Dechend, M Maass, J Gieffers, et al.
Journal of Reproductive Immunology
|
July 1, 2016
The association between angiogenic markers and fetal sex: Implications for preeclampsia research
L B Andersen, J S Jørgensen, F Herse, et al.
Oncogene
|
June 11, 1999
The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators
R Dechend, F Hirano, K Lehmann, et al.
Placenta
|
June 12, 2004
Pre-eclampsia as a 'three stage problem'--a workshop report
H Stepan, R Faber, U G Froster, et al.
International Journal of Cardiology
|
March 12, 2013
Ambulatory blood pressure monitoring: is it mandatory for blood pressure control in treated hypertensive patients?: prospective observational study
M V Lehmann, U Zeymer, R Dechend, et al.
American Journal of Hypertension
|
June 20, 2001
Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition
R Dechend, A Fiebler, C Lindschau, et al.
Page
of 5